4-hydroxymercuribenzoate has been researched along with Neuroblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakalkin, G; Ekström, TJ; Hallberg, M; Hauser, KF; Marinova, Z; Melzig, MF; Nylander, I; Ray, K; Rodgers, DW; Yakovleva, T | 1 |
Ducote, J; Frenkel, GD; Gierthy, J; Reboulleau, CP | 1 |
2 other study(ies) available for 4-hydroxymercuribenzoate and Neuroblastoma
Article | Year |
---|---|
A novel soluble protein factor with non-opioid dynorphin A-binding activity.
Topics: Animals; Brain; Carcinoma, Small Cell; Carrier Proteins; Cell Line; Cell Line, Tumor; Choriocarcinoma; DDT; Dynorphins; Humans; Hydroxymercuribenzoates; Kinetics; Lung Neoplasms; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Neuroblastoma; Neurons; Protease Inhibitors | 2004 |
A cell line with decreased sensitivity to the methyl mercury-induced stimulation of alpha-amanitin sensitive RNA synthesis in isolated nuclei.
Topics: Amanitins; Cell Line; Cell Nucleus; Drug Resistance; HeLa Cells; Humans; Hydroxymercuribenzoates; Methylmercury Compounds; Neuroblastoma; RNA, Neoplasm; Tumor Cells, Cultured | 1988 |